Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin Induced Thrombocytopenia (HIT)”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Study completedNCT00861692
What this trial is testing

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Who this might be right for
Heparin-induced Thrombocytopenia Type II
Tanabe Pharma Corporation 20
Post-approval studies (Phase 4)WithdrawnNCT00603824
What this trial is testing

Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
Methodist Healthcare - Memphis
Not applicableUnknownNCT00198575
What this trial is testing

A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients

Who this might be right for
Heparin-Induced Thrombocytopenia
Ministry of Health, Labour and Welfare, Japan 1,500
Large-scale testing (Phase 3)Study completedNCT00073580
What this trial is testing

Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)

Who this might be right for
ThrombocytopeniaThrombosisCardiac Disease+1 more
The Medicines Company 88
Early research (Phase 1)Study completedNCT05325346
What this trial is testing

A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects

Who this might be right for
Heparin-induced Thrombocytopenia
Veralox Therapeutics 12
Not applicableStudy completedNCT00283322
What this trial is testing

Heparin Antibodies in Intensive Care Unit Patients (HAICU)

Who this might be right for
Heparin-Induced Thrombocytopenia
The University of Texas Health Science Center, Houston 185
Early research (Phase 1)Study completedNCT00412464
What this trial is testing

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Who this might be right for
ThrombosisHeparin-induced Thrombocytopenia
Children's Hospital Los Angeles 24
Not applicableUnknownNCT05783895
What this trial is testing

Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery

Who this might be right for
Heparin-induced Thrombocytopenia
Central Hospital, Nancy, France 200
Not applicableUnknownNCT02717039
What this trial is testing

Pharmacogenomics of Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
University of Arizona 125
Not applicableNot Yet RecruitingNCT07817680
What this trial is testing

Cangrelor As Treatment for Cardiac Surgery Associated With Heparin Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
Société Française d'Anesthésie et de Réanimation 132
Not applicableUnknownNCT01102790
What this trial is testing

Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosis
Johann Wolfgang Goethe University Hospital 160
Not applicableUnknownNCT03148912
What this trial is testing

Optimizing the Diagnosis of Heparin Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia (HIT)
Ottawa Hospital Research Institute 180
Not applicableStudy completedNCT02526485
What this trial is testing

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

Who this might be right for
Heparin-induced Thrombocytopenia
Vanderbilt University Medical Center 15
Not applicableUnknownNCT00946400
What this trial is testing

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
Medstar Health Research Institute 500
Post-approval studies (Phase 4)Study completedNCT00039858
What this trial is testing

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Who this might be right for
ThrombocytopeniaThrombosis
Encysive Pharmaceuticals 24
Testing effectiveness (Phase 2)Ended earlyNCT05785819
What this trial is testing

VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Who this might be right for
Thrombocytopenia, ImmuneHeparin Induced Thrombocytopenia
Veralox Therapeutics 24
Not applicableStudy completedNCT05439265
What this trial is testing

EMR Tool Impact on HIT Documentation and Management

Who this might be right for
HeparinThrombocytopeniaElectronic Health Records
Rush University Medical Center 128
Not applicableUnknownNCT06180785
What this trial is testing

Performance Evaluation of the Biological Diagnosis of HIT

Who this might be right for
Heparin-induced Thrombocytopenia (HIT)
University Hospital, Strasbourg, France 894
Not applicableStudy completedNCT00748839
What this trial is testing

Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical

Who this might be right for
Heparin-induced Thrombocytopenia
Centre Hospitalier Universitaire de Saint Etienne 2,700
Not applicableUnknownNCT03269019
What this trial is testing

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosisBiomarkers
Wuhan Asia Heart Hospital 200
Next Page